News

Data suggest chemotherapy, anticancer treatments not significant contributors to worse outcomes in cancer patients with COVID-19

An analysis published in The Lancet of the largest cohort presented so far of cancer patients with coronavirus disease 2019 (COVID-19) has concluded that recent chemotherapy use is not a significant…

find out more

Celsius42 and hyperthermia on the advance in Asia

Charting a new course for cancer treatment in Asia Celsius42 GmbH has been represented in parts of Asia for many years, but decided, in order to generate extensive growth and meet regional standards,…

find out more

Celsius42 at Europe's largest medical congress for complementary medicine in Baden Baden

Eschweiler, 23 October 2019. Celsius42 will be present again in 2019 at the Medical Week Baden-Baden (Stand UG-35). The Medical Week (30.10.-3.11.2019) is known as one of the largest congress for…

find out more

IX. Hyperthermia Congress of the DGHT in Berlin

IX. Hyperthermia Congress in Berlin Once again the experts of the DGHT meet on September 20th and 21st for a clinical exchange. The aim of this event is to pass on evidence and a wealth of experience…

find out more

Contact

Celsius42 GmbH
Hermann-Hollerith-Str. 11
52249 Eschweiler
Deutschland

+49 (0) 24 03 – 7829 230
Send email

Celsius42 Korea LTD
Gunpo IT-Valley, S-B102, 17, Gosan-ro 148 Beon-gil,
Gunpo-city, Gyunggi-do,
South Korea

+82-70-5208 7622
Send email